Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.142 CHF
−115.23 M CHF
3.58 B CHF
120.86 M
About PROSIEBENSAT1 MEDIA SE
Sector
Industry
CEO
Bert Habets
Website
Headquarters
Unterfoehring
Founded
1998
ISIN
DE000PSM7770
FIGI
BBG006TLT248
ProSiebenSat.1 Media SE is a mass media and digital company. It operates through the following segments: Entertainment, Dating and Video, and Commerce & Ventures. The Entertainment segment represents the company's business with focus on the Seven.One Entertainment Group, which provides multi-platform digital media to audiences in Germany, Austria, and Switzerland. The Dating and Video segment offers a range of online matchmaking services and other social entertainment. The Commerce & Ventures segment supports young companies by offering media-for-revenue or media-for-equity partnership through its TV reach. The company was founded on January 1, 1984 and is headquartered in Unterfoehring, Germany.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of PSM is 4.716 CHF — it has increased by 6.53% in the past 24 hours. Watch PROSIEBENSAT1 MED. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BX exchange PROSIEBENSAT1 MED. stocks are traded under the ticker PSM.
We've gathered analysts' opinions on PROSIEBENSAT1 MED. future price: according to them, PSM price has a max estimate of 12.11 CHF and a min estimate of 4.66 CHF. Watch PSM chart and read a more detailed PROSIEBENSAT1 MED. stock forecast: see what analysts think of PROSIEBENSAT1 MED. and suggest that you do with its stocks.
PSM stock is 6.13% volatile and has beta coefficient of 1.31. Track PROSIEBENSAT1 MED. stock price on the chart and check out the list of the most volatile stocks — is PROSIEBENSAT1 MED. there?
Today PROSIEBENSAT1 MED. has the market capitalization of 1.07 B, it has increased by 1.53% over the last week.
Yes, you can track PROSIEBENSAT1 MED. financials in yearly and quarterly reports right on TradingView.
PROSIEBENSAT1 MED. is going to release the next earnings report on Mar 6, 2025. Keep track of upcoming events with our Earnings Calendar.
PSM earnings for the last quarter are 0.13 CHF per share, whereas the estimation was 0.15 CHF resulting in a −10.58% surprise. The estimated earnings for the next quarter are 0.67 CHF per share. See more details about PROSIEBENSAT1 MED. earnings.
PROSIEBENSAT1 MED. revenue for the last quarter amounts to 832.20 M CHF, despite the estimated figure of 829.37 M CHF. In the next quarter, revenue is expected to reach 1.23 B CHF.
PSM net income for the last quarter is 7.55 M CHF, while the quarter before that showed 13.48 M CHF of net income which accounts for −44.01% change. Track more PROSIEBENSAT1 MED. financial stats to get the full picture.
Yes, PSM dividends are paid annually. The last dividend per share was 0.05 CHF. As of today, Dividend Yield (TTM)% is 0.99%. Tracking PROSIEBENSAT1 MED. dividends might help you take more informed decisions.
As of Dec 28, 2024, the company has 7.19 K employees. See our rating of the largest employees — is PROSIEBENSAT1 MED. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. PROSIEBENSAT1 MED. EBITDA is 214.18 M CHF, and current EBITDA margin is 4.60%. See more stats in PROSIEBENSAT1 MED. financial statements.
Like other stocks, PSM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PROSIEBENSAT1 MED. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PROSIEBENSAT1 MED. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PROSIEBENSAT1 MED. stock shows the sell signal. See more of PROSIEBENSAT1 MED. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.